Combined Intratympanic and Systemic Steroid Therapy in Sudden Sensorineural Hearing Loss

Khadav, Sukhdev; Arya, Pooja; Gupta, Gaurav; Chand, Deep; Bishnoi, Ramchander; Chawra, Devendra Singh

doi:10.1007/s12070-020-02056-9

Cited by 1 publication

(1 citation statement)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In a study where three groups of patients were studied to assess intratympanic, systemic and combined therapy published in Indian Journal of Otolaryngology and Head and Neck Surgery, combined group where oral prednisolone 1mg/kg with a tapering dose over a period of 4 weeks and intratympanic dexamethasone 0.5ml every week for 4 weeks has produced better results. 9 . However, a similar study with a larger sample size but with different steroid combination didn't show a statistically different outcome between the groups.…”

Section: Combined Intratympanic Steroids and Systemic Steroidsmentioning

confidence: 99%

Sudden sensorineural hearing loss (SSNHL) evidence based management - state of the art

Lakshan

Drahaman²,

Perera

2020

Ceylon J Otolaryngology

View full text Add to dashboard Cite

Introduction Sudden sensorineural hearing loss (SSNHL) is defined as an acute hearing loss occurring within the period of three days (3) with the least magnitude of 30dB or more in three or more contiguous frequencies. Optimum management of SSNHL is disputed. This article attempts to review current literature on the subject and propose a protocol of management. Methods Latest guidelines on the SSNHL were accessed through Google Scholar database and reviewed for appropriateness. Studies assessing the management options were included. Efficacy of interventions were assessed, and recommendations made. Results 17 publications including European Consensus Document and AAO HNS recommendation were assessed. Conclusions 1. Systemic steroids use has a clear definitive recommendation in unison. 2. Intratympanic steroid use has been proposed mainly for salvage therapy. 3. Combined modality treatment options have been used with mixed outcome. 4. Based on the findings a protocol for management of SSNHL is proposed.

show abstract

Section: Combined Intratympanic Steroids and Systemic Steroidsmentioning

confidence: 99%